Chargement en cours...
Docetaxel induces Bcl-2- and pro-apoptotic caspase-independent death of human prostate cancer DU145 cells
Docetaxel is a useful chemotherapeutic agent for the first-line treatment of hormone-refractory prostate cancer. Abnormal expression of Bcl-2 is commonly found in cancer cells, which increases their anti-apoptotic potency and chemo-resistance. We investigated the effects of Bcl-2 expression status o...
Enregistré dans:
| Publié dans: | Int J Oncol |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
D.A. Spandidos
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4864052/ https://ncbi.nlm.nih.gov/pubmed/27082738 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ijo.2016.3482 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|